Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-29 Sale | 2024-10-31 6:01 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.7202 | $76,926 | 7,077,560 (Direct) | View |
| 2024-10-15 Sale | 2024-10-17 5:27 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.6678 | $76,326 | 7,089,007 (Direct) | View |
| 2024-10-01 Sale | 2024-10-03 4:58 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.2156 | $71,150 | 7,098,428 (Direct) | View |
| 2024-09-17 Sale | 2024-09-19 5:48 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.8431 | $78,333 | 7,109,875 (Direct) | View |
| 2024-09-03 Sale | 2024-09-05 5:25 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.2652 | $71,718 | 7,121,322 (Direct) | View |
| 2024-08-20 Sale | 2024-08-22 6:48 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $7.1226 | $81,532 | 7,132,769 (Direct) | View |
| 2024-08-06 Sale | 2024-08-08 5:23 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.8213 | $78,083 | 7,144,216 (Direct) | View |
| 2024-07-23 Sale | 2024-07-25 6:15 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $8.4774 | $97,041 | 7,155,663 (Direct) | View |
| 2024-07-09 Sale | 2024-07-11 4:51 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $7.315 | $83,735 | 7,167,110 (Direct) | View |
| 2024-06-25 Sale | 2024-06-27 7:13 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $9.5052 | $108,806 | 7,177,116 (Direct) | View |
| 2024-06-11 Sale | 2024-06-13 5:36 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $8.4531 | $96,763 | 7,188,563 (Direct) | View |
| 2024-05-28 Sale | 2024-05-30 6:41 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $9.1677 | $104,943 | 7,186,913 (Direct) | View |
| 2024-05-14 Sale | 2024-05-16 4:35 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $10.12 | $202,934 | 7,198,360 (Direct) | View |
| 2024-04-30 Sale | 2024-05-02 5:41 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $7.9465 | $90,964 | 7,218,414 (Direct) | View |
| 2024-04-16 Sale | 2024-04-18 5:12 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $7.6636 | $87,725 | 7,229,861 (Direct) | View |
| 2024-04-02 Sale | 2024-04-03 5:42 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $8.8182 | $100,942 | 7,241,308 (Direct) | View |
| 2024-03-19 Sale | 2024-03-21 5:38 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $10.79 | $216,423 | 7,252,755 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 6:53 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $12.06 | $241,805 | 7,272,809 (Direct) | View |
| 2024-02-20 Sale | 2024-02-21 5:37 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $12.32 | $247,125 | 7,292,863 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 6:54 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $9.3028 | $106,489 | 7,312,917 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 6:13 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $10.58 | $212,083 | 7,324,364 (Direct) | View |
| 2024-01-09 Sale | 2024-01-11 6:50 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $13.62 | $273,202 | 7,344,418 (Direct) | View |
| 2023-12-26 Sale | 2023-12-28 5:48 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $10.63 | $213,144 | 7,364,472 (Direct) | View |
| 2023-12-12 Sale | 2023-12-14 6:51 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $7.3987 | $84,693 | 7,384,526 (Direct) | View |
| 2023-11-28 Sale | 2023-11-30 5:41 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.7195 | $76,918 | 7,395,973 (Direct) | View |
| 2023-11-14 Sale | 2023-11-16 6:55 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $6.3197 | $56,151 | 7,407,420 (Direct) | View |
| 2023-10-31 Sale | 2023-11-02 7:02 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $5.2745 | $46,864 | 7,416,305 (Direct) | View |
| 2023-10-17 Sale | 2023-10-19 5:34 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $6.5822 | $58,483 | 7,425,190 (Direct) | View |
| 2023-10-03 Sale | 2023-10-05 6:25 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $7.2907 | $64,778 | 7,434,075 (Direct) | View |
| 2023-09-19 Sale | 2023-09-21 6:35 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.3599 | $74,278 | 7,442,960 (Direct) | View |
| 2023-09-05 Sale | 2023-09-07 7:02 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.7942 | $78,136 | 7,451,845 (Direct) | View |
| 2023-08-22 Sale | 2023-08-24 5:51 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.9118 | $79,181 | 7,460,730 (Direct) | View |
| 2023-08-08 Sale | 2023-08-10 5:33 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 17,770 | $11.16 | $198,283 | 7,469,615 (Direct) | View |
| 2023-07-25 Sale | 2023-07-27 6:30 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 18,719 | $14.61 | $273,464 | 7,487,385 (Direct) | View |
| 2023-07-11 Sale | 2023-07-13 4:54 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $6.8873 | $61,194 | 7,520,104 (Direct) | View |
| 2023-06-27 Sale | 2023-06-29 5:57 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $7.3876 | $65,639 | 7,528,989 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-01 Option Award | 2024-10-04 6:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 2,026 | $0 | 7,100,454 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 4:39 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 1,441 | $0 | 7,178,557 (Direct) | View |
| 2024-06-03 Option Award | 2024-06-05 6:12 pm | N/A 2034-06-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 39,290 | $0 | 7,226,203 (Direct) | View |
| 2023-06-29 Gift | 2023-07-27 6:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 14,000 | $0 | 7,487,385 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:24 pm | 2024-06-16 2033-06-16 | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 37,836 | $0 | 7,611,888 (Direct) | View |